CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. 1996

M K Kennedy, and K S Picha, and W C Fanslow, and K H Grabstein, and M R Alderson, and K N Clifford, and W A Chin, and K M Mohler
Immunex Corporation, Seattle, USA.

We have previously shown that T cell receptor-activated mouse T helper (Th)1 clones induce the production of interleukin (IL)-12 by splenic antigen-presenting cells (APC). Here, we show that the expression of CD40L by activated T cells is critical for T cell-dependent IL-12 production by mouse macrophages. IL-12 was produced in cultures containing alloreactive Th1 clones stimulated with allogeneic peritoneal macrophages, or in cultures of splenocytes stimulated with anti-CD3. Anti-CD40L monoclonal antibodies (mAb) inhibited the production of IL-12, but not IL-2, in these cultures by approximately 90% and had dramatic inhibitory effects on antigen-dependent proliferation of Th1 clones. In addition, both activated T cells and a Th1 clone derived from CD40L knockout mice failed to induce IL-12 production from splenic APC or peritoneal macrophages. Finally, macrophages cultured in the absence of T cells produced IL-12 upon stimulation with soluble recombinant CD40L in combination with either supernatants from activated Th1 clones or with interferon-gamma and granulocyte/macrophage colony-stimulating factor. Thus, both CD40L-dependent and cytokine-mediated signals from activated T cells are required to induce the production of IL-12 by macrophages. A blockade at the level of IL-12 production may explain, at least in part, the dramatic ability of anti-CD40L mAb to inhibit disease in animal models that are dependent upon the generation of a cell-mediated immune response. Moreover, a defect in T cell-dependent induction of IL-12 may contribute to the immune status of humans that lack functional CD40L.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002474 Cell-Free System A fractionated cell extract that maintains a biological function. A subcellular fraction isolated by ultracentrifugation or other separation techniques must first be isolated so that a process can be studied free from all of the complex side reactions that occur in a cell. The cell-free system is therefore widely used in cell biology. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p166) Cellfree System,Cell Free System,Cell-Free Systems,Cellfree Systems,System, Cell-Free,System, Cellfree,Systems, Cell-Free,Systems, Cellfree
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug

Related Publications

M K Kennedy, and K S Picha, and W C Fanslow, and K H Grabstein, and M R Alderson, and K N Clifford, and W A Chin, and K M Mohler
April 1995, European journal of immunology,
M K Kennedy, and K S Picha, and W C Fanslow, and K H Grabstein, and M R Alderson, and K N Clifford, and W A Chin, and K M Mohler
October 1996, Annals of the New York Academy of Sciences,
M K Kennedy, and K S Picha, and W C Fanslow, and K H Grabstein, and M R Alderson, and K N Clifford, and W A Chin, and K M Mohler
February 2000, Immunology,
M K Kennedy, and K S Picha, and W C Fanslow, and K H Grabstein, and M R Alderson, and K N Clifford, and W A Chin, and K M Mohler
January 1997, Proceedings of the National Academy of Sciences of the United States of America,
M K Kennedy, and K S Picha, and W C Fanslow, and K H Grabstein, and M R Alderson, and K N Clifford, and W A Chin, and K M Mohler
November 1993, The Journal of experimental medicine,
M K Kennedy, and K S Picha, and W C Fanslow, and K H Grabstein, and M R Alderson, and K N Clifford, and W A Chin, and K M Mohler
May 1996, The Journal of experimental medicine,
M K Kennedy, and K S Picha, and W C Fanslow, and K H Grabstein, and M R Alderson, and K N Clifford, and W A Chin, and K M Mohler
May 1996, Journal of immunology (Baltimore, Md. : 1950),
M K Kennedy, and K S Picha, and W C Fanslow, and K H Grabstein, and M R Alderson, and K N Clifford, and W A Chin, and K M Mohler
January 1997, Journal of immunology (Baltimore, Md. : 1950),
M K Kennedy, and K S Picha, and W C Fanslow, and K H Grabstein, and M R Alderson, and K N Clifford, and W A Chin, and K M Mohler
December 1997, The Journal of experimental medicine,
M K Kennedy, and K S Picha, and W C Fanslow, and K H Grabstein, and M R Alderson, and K N Clifford, and W A Chin, and K M Mohler
January 1995, Research in immunology,
Copied contents to your clipboard!